237 related articles for article (PubMed ID: 3917279)
1. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
Thompson CB; Schaefer ME; Finkelman FD; Scher I; Farrar J; Mond JJ
J Immunol; 1985 Jan; 134(1):369-74. PubMed ID: 3917279
[TBL] [Abstract][Full Text] [Related]
2. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
5. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
6. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
7. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
8. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
9. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
10. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
Ennist DL; Elkins KL; Cheng SC; Howard M
J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
[TBL] [Abstract][Full Text] [Related]
11. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
[TBL] [Abstract][Full Text] [Related]
13. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
Zubler RH; Erard F; Lees RK; Van Laer M; Mingari C; Moretta L; MacDonald HR
J Immunol; 1985 Jun; 134(6):3662-8. PubMed ID: 3886789
[TBL] [Abstract][Full Text] [Related]
14. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
17. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
Kehrl JH; Muraguchi A; Fauci AS
Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
[TBL] [Abstract][Full Text] [Related]
18. Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies.
MacDonald HR; Lees RK; Bron C
J Immunol; 1985 Dec; 135(6):3944-50. PubMed ID: 2415592
[TBL] [Abstract][Full Text] [Related]
19. Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors.
Layton JE; Krammer PH; Hamaoka T; Uhr JW; Vitetta ES
J Mol Cell Immunol; 1985; 2(3):155-67. PubMed ID: 2978227
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]